Despite promising evidence, several important research gaps remain
The difference between the two therapeutic approaches is the continuous chronic secretion of leptin mediated by gene delivery versus the intermittent bolus delivery and rapid clearance of daily injection of rh-leptin protein (Morsy et al., 1998)
A method of detecting VEGF, comprising contacting a composition suspected of containing VEGF with the antibody of any one of claims 1 to 20, or an immunoconjugate thereof, under conditions effective to allow the formation of VEGF/antibody complexes and detecting the complexes so formed
Treatment with proton pump inhibitors (PPIs) or H2 blockers can address the acid component, often reducing burping as a secondary benefit
According to a 2024 report by Harvard Health, the Food and Drug Administration has approved a total of 10 GLP-1 medications for treating diabetes and obesity, with other applications like drug addiction still being studied